JP2009535342A - 眼瞼腫脹の予防および処置のための組成物 - Google Patents

眼瞼腫脹の予防および処置のための組成物 Download PDF

Info

Publication number
JP2009535342A
JP2009535342A JP2009507810A JP2009507810A JP2009535342A JP 2009535342 A JP2009535342 A JP 2009535342A JP 2009507810 A JP2009507810 A JP 2009507810A JP 2009507810 A JP2009507810 A JP 2009507810A JP 2009535342 A JP2009535342 A JP 2009535342A
Authority
JP
Japan
Prior art keywords
composition
naphazoline
group
agent
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009507810A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009535342A5 (enExample
Inventor
マシュー ジョナサン チャッピン，
マーク バリー アベルソン，
アキミツ マキノ，
キース ジェフリー レーン，
Original Assignee
アーシエックス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アーシエックス， インコーポレイテッド filed Critical アーシエックス， インコーポレイテッド
Publication of JP2009535342A publication Critical patent/JP2009535342A/ja
Publication of JP2009535342A5 publication Critical patent/JP2009535342A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2009507810A 2006-04-26 2007-04-26 眼瞼腫脹の予防および処置のための組成物 Pending JP2009535342A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79498306P 2006-04-26 2006-04-26
US84547906P 2006-09-18 2006-09-18
PCT/US2007/010177 WO2007127333A2 (en) 2006-04-26 2007-04-26 Compositions for the treatment and prevention of eyelid swelling

Publications (2)

Publication Number Publication Date
JP2009535342A true JP2009535342A (ja) 2009-10-01
JP2009535342A5 JP2009535342A5 (enExample) 2011-06-16

Family

ID=38656195

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009507810A Pending JP2009535342A (ja) 2006-04-26 2007-04-26 眼瞼腫脹の予防および処置のための組成物

Country Status (7)

Country Link
US (3) US8685439B2 (enExample)
EP (1) EP2015733A2 (enExample)
JP (1) JP2009535342A (enExample)
AU (1) AU2007243334A1 (enExample)
CA (1) CA2650592A1 (enExample)
MX (1) MX2008013783A (enExample)
WO (1) WO2007127333A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014506927A (ja) * 2011-03-03 2014-03-20 ブーム・リミテッド・ライアビリティ・カンパニー 眼瞼下垂症の非外科的治療用組成物および方法
JP2023544680A (ja) * 2020-09-11 2023-10-25 イントラタス－ネバダ インコーポレイテッド 老視、遠視、乱視、低減した立体視、および低下したコントラスト感度を治療するための組成物および方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685439B2 (en) 2006-04-26 2014-04-01 Aciex Therapeutics, Inc. Method for the treatment and prevention of eyelid swelling
MX2010005012A (es) * 2007-11-08 2010-06-23 Aciex Therapeutics Inc Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
RU2600863C2 (ru) * 2007-12-10 2016-10-27 Сентисс Фарма Прайвит Лимитед Офтальмическая композиция, включающая фенилэфрин
US8778999B2 (en) 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
CA3239245A1 (en) 2009-08-26 2011-03-10 Mary Kay Inc. Topical skin care formulations comprising plant extracts
CA2850964C (en) 2011-10-05 2021-02-02 Jennifer L. Sanders Methods and compositions for treating foot or hand pain
US20150044136A1 (en) * 2013-08-12 2015-02-12 George H. Scherr Ophthalmological treatment for michobial infections
US9874379B2 (en) * 2014-07-09 2018-01-23 Hamilton Sundstrand Corporation Expendable driven heat pump cycles
US9820954B2 (en) 2015-08-19 2017-11-21 Jenivision Inc. Quantitative peri-orbital application of ophthalmology drugs
CN115006537A (zh) * 2016-01-26 2022-09-06 利维申制药有限公司 α-肾上腺素能药剂的组合物和用途
JP2021532079A (ja) * 2018-07-12 2021-11-25 オキュソフト インコーポレイテッドOCuSOFT, Inc. 目の抗アレルギ用組成物および眼瞼洗浄ワイプ
US11077150B2 (en) * 2018-10-09 2021-08-03 Massoumeh Kharazmi Methods and compositions for treatment of eye conditions
US10814001B1 (en) 2019-05-06 2020-10-27 Rvl Pharmaceuticals, Inc. Oxymetazoline compositions
US20230012731A1 (en) * 2019-11-26 2023-01-19 Standard Of Care Corporation Hyaluronidase compositions and methods of using same to treat peri-orbital hollowness and tear through deformities
AU2023352919A1 (en) 2022-09-29 2025-03-13 Adora Life Science, Inc. Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08217678A (ja) * 1993-12-27 1996-08-27 Senju Pharmaceut Co Ltd ジフルプレドナート含有点眼用懸濁液剤
WO2001054684A1 (en) * 2000-01-26 2001-08-02 Kyorin Pharmaceutical Co., Ltd. Eye drops
JP2004123729A (ja) * 2002-09-09 2004-04-22 Santen Pharmaceut Co Ltd ラタノプロストを有効成分とする澄明な点眼液

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2618428A (en) 1947-01-27 1952-11-18 John K M Harrison Shock resistant container
JPS6056684B2 (ja) 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4407792A (en) 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
LU83173A1 (fr) 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4454151A (en) 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
JPH0830004B2 (ja) 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US4960799A (en) 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
IT1248014B (it) 1991-06-07 1995-01-05 Inverni Della Beffa Spa Preparazioni oftalmiche a rilascio protratto
AU684115B2 (en) 1993-12-27 1997-12-04 Mitsubishi Chemical Corporation Ophthalmic suspension containing diflupredonate
US5811446A (en) 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US6274626B1 (en) 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
AU781964B2 (en) * 1999-06-08 2005-06-23 Naturveda Non-solid composition for local application
CZ295595B6 (cs) * 1999-06-22 2005-08-17 Boehringer Ingelheim International Gmbh Stálý roztok xylometazolinu a oxymetazolinu
JP2001187728A (ja) 1999-12-28 2001-07-10 Lion Corp 眼科用組成物
DE10000612A1 (de) 2000-01-10 2001-07-19 Min Becker Flüssigkeitspräparate für Augen- und Nasen-Tropfen bzw. Nasenspray ohne Konservierungsmittel
US6572849B2 (en) * 2000-09-20 2003-06-03 Lee Shahinian, Jr. Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
JP2002308775A (ja) 2001-04-06 2002-10-23 Rohto Pharmaceut Co Ltd 外用組成物
US6806364B2 (en) 2002-07-29 2004-10-19 Ast Products, Inc. Ophthalmic compositions
AU2003272517A1 (en) * 2002-09-13 2004-04-30 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
US20050059639A1 (en) * 2003-09-11 2005-03-17 Wei Edward T. Ophthalmic compositions and method for treating eye discomfort and pain
US7288263B2 (en) 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
PL2486942T3 (pl) 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
JP2006232792A (ja) 2005-02-21 2006-09-07 Aile De Beaute:Kk 肌老化改善化粧料
SG170044A1 (en) 2006-03-31 2011-04-29 Vistakon Pharmaceuticals Llc Ocular allergy treatments
US8685439B2 (en) * 2006-04-26 2014-04-01 Aciex Therapeutics, Inc. Method for the treatment and prevention of eyelid swelling

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08217678A (ja) * 1993-12-27 1996-08-27 Senju Pharmaceut Co Ltd ジフルプレドナート含有点眼用懸濁液剤
WO2001054684A1 (en) * 2000-01-26 2001-08-02 Kyorin Pharmaceutical Co., Ltd. Eye drops
JP2004123729A (ja) * 2002-09-09 2004-04-22 Santen Pharmaceut Co Ltd ラタノプロストを有効成分とする澄明な点眼液

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JPN6012039373; 日本大衆薬情報研究会: 大衆薬辞典２００６〜'０７（一般用医薬品集　第１０版） , 20060420, ｐ．２３８-２３９ *
JPN6012039375; Ｃｌｉｎｉｃａｌ　Ｔｈｅｒａｐｅｕｔｉｃｓ ｖｏｌ．２７，　ｎｏ．５, 2005, ｐ．５６８-５７７ *
JPN6012039377; 株式会社日本点眼薬研究所: 眼科用収斂剤オフサリンＰ硫酸亜鉛点眼液（添付文書） , 1999 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014506927A (ja) * 2011-03-03 2014-03-20 ブーム・リミテッド・ライアビリティ・カンパニー 眼瞼下垂症の非外科的治療用組成物および方法
JP2023544680A (ja) * 2020-09-11 2023-10-25 イントラタス－ネバダ インコーポレイテッド 老視、遠視、乱視、低減した立体視、および低下したコントラスト感度を治療するための組成物および方法
JP7766680B2 (ja) 2020-09-11 2025-11-10 イントラタス－ネバダ インコーポレイテッド 老視、遠視、乱視、低減した立体視、および低下したコントラスト感度を治療するための組成物および方法

Also Published As

Publication number Publication date
AU2007243334A1 (en) 2007-11-08
WO2007127333A2 (en) 2007-11-08
US20120021072A1 (en) 2012-01-26
US8685439B2 (en) 2014-04-01
US20070264318A1 (en) 2007-11-15
WO2007127333A3 (en) 2008-08-07
US20140161903A1 (en) 2014-06-12
EP2015733A2 (en) 2009-01-21
MX2008013783A (es) 2009-02-05
CA2650592A1 (en) 2007-11-08

Similar Documents

Publication Publication Date Title
US8685439B2 (en) Method for the treatment and prevention of eyelid swelling
JP2011503061A (ja) 浸透圧活性剤及び血管収縮剤を含む眼けん腫脹の治療及び防止のための組成物
US20210177807A1 (en) Compositions for the treatment and prevention of eyelid swelling
JP7088980B2 (ja) セチリジンの眼科用製剤および使用方法
US20070254841A1 (en) Formulations and methods for treating dry eye
US20100240624A1 (en) Ophthalmic Formulations of Ketotifen and Methods of Use
US20100311688A1 (en) Ophthalmic formulations, methods of manufacture, and methods of using same
CN103501771B (zh) 用于上睑下垂的非手术治疗的组合物和方法
US20070297981A1 (en) Formulations and methods for treating dry eye
JP2010528014A (ja) ドライアイを処置するための処方物および方法
JP2022048282A (ja) シクロデキストリンを用いるアレルギーの眼の状態の処置
US20070299124A1 (en) Formulations and methods for treating dry eye
CN101460152A (zh) 治疗以及预防眼皮肿胀的组合物
BR112020018377A2 (pt) Métodos de uso e composições farmacêuticas de um inibidor de syk seletivo

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100423

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100423

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110415

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120730

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120824

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120831

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130508